{"pageContent": "Background: Men with low- to intermediate-risk prostate cancer are typically asked to choose from a variety of treatment options, including active surveillance, radical prostatectomy, or brachytherapy. The Prolaris cell cycle progression test is intended to provide additional information on personal risk status to assist men with prostate cancer in their choice of treatment. To assist with assessing that new technology, this report synthesizes qualitative research on how men with prostate cancer use information to make decisions about treatment options.", "metaData": {"source": "Urinary symptoms, potency, and quality of life in patients with localized prostate cancer followed up with deferred treatment\nhttps://pubmed.ncbi.nlm.nih.gov/9836554/"}}